PL1613589T3 - Nowy difenyloazetydynon o polepszonych właściwościach fizjologicznych, sposób jego wytwarzania, środki lecznicze zawierające ten związek i jego zastosowanie - Google Patents

Nowy difenyloazetydynon o polepszonych właściwościach fizjologicznych, sposób jego wytwarzania, środki lecznicze zawierające ten związek i jego zastosowanie

Info

Publication number: PL1613589T3
Authority: PL; Poland
Prior art keywords: compound; production method; physiological characteristics; corresponding production; medicaments containing
Prior art date: 2003-04-01

Application number

PL04720854T

Other languages

English (en)

Inventor

Gerhard Jaehne

Wendelin Frick

Andreas Lindenschmidt

Stefanie Flohr

Hubert Heuer

Hans-Ludwig Schaefer

Werner Kramer

Eric Galia

Heiner Glombik

Original Assignee

Sanofi Aventis Deutschland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-01

Filing date

2004-03-16

Publication date

2008-07-31

2004-03-16 Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland

2008-07-31 Publication of PL1613589T3 publication Critical patent/PL1613589T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

PL04720854T 2003-04-01 2004-03-16 Nowy difenyloazetydynon o polepszonych właściwościach fizjologicznych, sposób jego wytwarzania, środki lecznicze zawierające ten związek i jego zastosowanie PL1613589T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10314610A DE10314610A1 (de)	2003-04-01	2003-04-01	Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung
PCT/EP2004/002690 WO2004087655A1 (de)	2003-04-01	2004-03-16	Neues diphenylazetidinon mit verbesserten physiologischen eigenschaften, verfahren zu dessen herstellung, diese verbindungen enthaltende arzneimittel und dessen verwendung
EP04720854A EP1613589B1 (de)	2003-04-01	2004-03-16	Neues diphenylazetidinon mit verbesserten physiologischen eigenschaften, verfahren zu dessen herstellung, diese verbindung enthaltende arzneimittel und dessen verwendung

Publications (1)

Publication Number	Publication Date
PL1613589T3 true PL1613589T3 (pl)	2008-07-31

Family

ID=33103147

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL04720854T PL1613589T3 (pl)	2003-04-01	2004-03-16	Nowy difenyloazetydynon o polepszonych właściwościach fizjologicznych, sposób jego wytwarzania, środki lecznicze zawierające ten związek i jego zastosowanie
PL07016889T PL1862455T3 (pl)	2003-04-01	2004-03-16	Kwas 11-((4R,6R)-4,5,6-trihydroksy-3-(R)-hydroksy-2-(S)-hydroksy-heksylokarbamoilo)-undekanowy

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL07016889T PL1862455T3 (pl)	2003-04-01	2004-03-16	Kwas 11-((4R,6R)-4,5,6-trihydroksy-3-(R)-hydroksy-2-(S)-hydroksy-heksylokarbamoilo)-undekanowy

Country Status (44)

Country	Link
US (2)	US7205290B2 (pl)
EP (2)	EP1613589B1 (pl)
JP (1)	JP2006522040A (pl)
KR (1)	KR20050119180A (pl)
CN (2)	CN100361970C (pl)
AR (1)	AR043783A1 (pl)
AT (2)	ATE423766T1 (pl)
AU (1)	AU2004226287B2 (pl)
BR (1)	BRPI0408920A (pl)
CA (1)	CA2520689A1 (pl)
CL (1)	CL43489B (pl)
CR (1)	CR7995A (pl)
CY (2)	CY1107398T1 (pl)
DE (3)	DE10314610A1 (pl)
DK (2)	DK1862455T3 (pl)
EC (1)	ECSP056071A (pl)
ES (2)	ES2298731T3 (pl)
GT (1)	GT200400058A (pl)
HK (1)	HK1087697A1 (pl)
HN (1)	HN2004000109A (pl)
HR (1)	HRP20050870A2 (pl)
JO (1)	JO2493B1 (pl)
MA (1)	MA27753A1 (pl)
ME (1)	MEP41408A (pl)
MX (1)	MXPA05010128A (pl)
MY (1)	MY136269A (pl)
NI (1)	NI200500164A (pl)
NO (1)	NO20055001L (pl)
NZ (1)	NZ542751A (pl)
PA (1)	PA8599401A1 (pl)
PE (1)	PE20050011A1 (pl)
PL (2)	PL1613589T3 (pl)
PT (2)	PT1862455E (pl)
RS (1)	RS51146B (pl)
RU (1)	RU2334737C2 (pl)
SA (1)	SA04250154B1 (pl)
SI (2)	SI1613589T1 (pl)
SV (1)	SV2004001756A (pl)
TN (1)	TNSN05244A1 (pl)
TW (1)	TW200504009A (pl)
UA (1)	UA80754C2 (pl)
UY (1)	UY28253A1 (pl)
WO (1)	WO2004087655A1 (pl)
ZA (1)	ZA200506708B (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE50111751D1 (de) *	2000-12-21	2007-02-08	Sanofi Aventis Deutschland	Neue diphenzylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung zur behandlung von lipidstoffwechselstörungen
US7635705B2 (en)	2005-06-20	2009-12-22	Schering Corporation	Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
US7067689B1 (en)	2005-07-08	2006-06-27	Microbia, Inc.	Process for production of pentahydroxyhexylcarbamoyl alkanoic acids
RU2009108280A (ru)	2006-08-08	2010-09-20	Санофи-Авентис (Fr)	Ариламиноарилалкилзамещенные имидазолидин-2,4-дионы, способы их получения, содержащие эти соединения лекарственные средства и их применение
US20080319218A1 (en) *	2007-06-22	2008-12-25	Andreas Haubrich	Processes for Making and Using Benzyl Pentahydroxyhexylcarbamoylundecanoate
US20080319221A1 (en) *	2007-06-22	2008-12-25	Bernd Junker	Esters of Pentahydroxyhexylcarbamoyl Alkanoic Acids
DE102007029612A1 (de) *	2007-06-27	2009-01-08	Sanofi-Aventis Deutschland Gmbh	Verfahren zur Herstellung von Pentahydroxyhexylcarbamoylundekan- säurebenzylester
EP2025674A1 (de)	2007-08-15	2009-02-18	sanofi-aventis	Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102007054497B3 (de) *	2007-11-13	2009-07-23	Sanofi-Aventis Deutschland Gmbh	Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung
KR20100113602A (ko) *	2008-02-05	2010-10-21	하버 바이오사이언시즈 인코포레이티드	고체 형태의 약제
WO2009112203A1 (de) *	2008-03-14	2009-09-17	Sanofi-Aventis Deutschland Gmbh	Verfahren zur herstellung eines diphenylazetidinons
DE102008059772A1 (de)	2008-12-01	2010-06-02	Sanofi-Aventis Deutschland Gmbh	Verfahren zur Herstellung eines Diphenylazetidinons
DE102010015123A1 (de)	2010-04-16	2011-10-20	Sanofi-Aventis Deutschland Gmbh	Benzylamidische Diphenylazetidinone, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
EP2582709B1 (de)	2010-06-18	2018-01-24	Sanofi	Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
WO2012120057A1 (de)	2011-03-08	2012-09-13	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120052A1 (de)	2011-03-08	2012-09-13	Sanofi	Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683701B1 (de)	2011-03-08	2014-12-24	Sanofi	Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8828994B2 (en)	2011-03-08	2014-09-09	Sanofi	Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120056A1 (de)	2011-03-08	2012-09-13	Sanofi	Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683702B1 (de)	2011-03-08	2014-12-24	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683699B1 (de)	2011-03-08	2015-06-24	Sanofi	Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8809325B2 (en)	2011-03-08	2014-08-19	Sanofi	Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
WO2012120053A1 (de)	2011-03-08	2012-09-13	Sanofi	Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2567959B1 (en)	2011-09-12	2014-04-16	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US10426480B2 (en) *	2015-04-29	2019-10-01	Covidien Lp	Cutting ring assembly with rigid cutting member

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2663336B1 (fr)	1990-06-18	1992-09-04	Adir	Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5756740A (en) *	1992-04-08	1998-05-26	Eastman Kodak Company	Process for the preparation of binary sensitizing dyes
FR2713225B1 (fr)	1993-12-02	1996-03-01	Sanofi Sa	N-pipéridino-3-pyrazolecarboxamide substitué.
JP3071832B2 (ja)	1996-01-17	2000-07-31	ノボノルディスクアクティーゼルスカブ	縮合した１，２，４−チアジアジン及び縮合した１，４−チアジン誘導体、これらの製造および使用
DE122009000079I2 (de)	1996-08-30	2011-06-16	Novo Nordisk As Novo Alle	Glp-1 derivate
US5756470A (en) *	1996-10-29	1998-05-26	Schering Corporation	Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
DE19726167B4 (de) *	1997-06-20	2008-01-24	Sanofi-Aventis Deutschland Gmbh	Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
JP2001510195A (ja)	1997-07-16	2001-07-31	ノボノルディスクアクティーゼルスカブ	縮合化１，２，４−チアジアジン誘導体、その調製及び使用
CO4970713A1 (es)	1997-09-19	2000-11-07	Sanofi Synthelabo	Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
KR100595332B1 (ko)	1998-03-12	2006-07-03	데이진 가부시키가이샤	벤조푸릴피론 유도체
US6221897B1 (en) *	1998-06-10	2001-04-24	Aventis Pharma Deutschland Gmbh	Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DE19845405C2 (de) *	1998-10-02	2000-07-13	Aventis Pharma Gmbh	Arylsubstituierte Propanolaminderivate und deren Verwendung
CZ295768B6 (cs)	1998-12-07	2005-10-12	Societe De Conseils De Recherches Et D'application	Analogy GLP-1, mající beta-alanin na pozici 35, jejich použití a farmaceutické prostředky je obsahující
GB9900416D0 (en)	1999-01-08	1999-02-24	Alizyme Therapeutics Ltd	Inhibitors
HUP0201291A3 (en)	1999-04-28	2002-11-28	Sanofi Aventis Deutschland	Di-aryl acid derivatives as ppar receptor ligands and pharmaceutical compositions containing them
KR100693771B1 (ko)	1999-04-28	2007-03-12	사노피-아벤티스 도이칠란트 게엠베하	Ｐｐａｒ 수용체 리간드로서의 트리아릴 산 유도체 및 이를 포함하는 약제학적 조성물
GB9911863D0 (en)	1999-05-21	1999-07-21	Knoll Ag	Therapeutic agents
ES2265952T3 (es)	1999-06-18	2007-03-01	MERCK & CO., INC.	Derivados de ariltiazolidindiona y ariloxazolidindiona.
EP1076066A1 (en)	1999-07-12	2001-02-14	Zealand Pharmaceuticals A/S	Peptides for lowering blood glucose levels
WO2001009111A1 (en)	1999-07-29	2001-02-08	Eli Lilly And Company	Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists
JP4792186B2 (ja) *	1999-09-01	2011-10-12	サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	スルホニルカルボキサミド誘導体、その調製方法および医薬としてのその使用
JP2003523396A (ja)	2000-02-25	2003-08-05	ノボノルディスクアクティーゼルスカブ	ベータ細胞変性の抑制
AU5257401A (en)	2000-04-28	2001-11-12	Asahi Chemical Ind	Novel bicyclic compounds
AU5959201A (en)	2000-05-11	2001-11-20	Bristol Myers Squibb Co	Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
SE0001899D0 (sv)	2000-05-22	2000-05-22	Pharmacia & Upjohn Ab	New compounds
HUP0004741A2 (hu)	2000-11-28	2002-12-28	Sanofi-Synthelabo	Kémiai eljárás tiazolszármazékok előállítására és új intermedier
DE50111751D1 (de) *	2000-12-21	2007-02-08	Sanofi Aventis Deutschland	Neue diphenzylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung zur behandlung von lipidstoffwechselstörungen
DE10139416A1 (de)	2001-08-17	2003-03-06	Aventis Pharma Gmbh	Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
KR100915108B1 (ko) *	2001-08-31	2009-09-03	사노피-아벤티스 도이칠란트 게엠베하	Ｐｐａｒ-활성화제로서의 디아릴사이클로알킬 유도체 및 이를 포함하는 약제학적 조성물
US6884812B2 (en) *	2001-08-31	2005-04-26	Aventis Pharma Deutschland Gmbh	Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
US7176194B2 (en) *	2002-06-19	2007-02-13	Sanofi-Aventis Deutschland Gmbh	Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
GB0215579D0 (en) *	2002-07-05	2002-08-14	Astrazeneca Ab	Chemical compounds

2003
- 2003-04-01 DE DE10314610A patent/DE10314610A1/de not_active Withdrawn
2004
- 2004-02-24 JO JO200418A patent/JO2493B1/en active
- 2004-03-16 PL PL04720854T patent/PL1613589T3/pl unknown
- 2004-03-16 MX MXPA05010128A patent/MXPA05010128A/es active IP Right Grant
- 2004-03-16 DK DK07016889T patent/DK1862455T3/da active
- 2004-03-16 ES ES04720854T patent/ES2298731T3/es not_active Expired - Lifetime
- 2004-03-16 KR KR1020057018705A patent/KR20050119180A/ko not_active Application Discontinuation
- 2004-03-16 AU AU2004226287A patent/AU2004226287B2/en not_active Ceased
- 2004-03-16 ME MEP-414/08A patent/MEP41408A/xx unknown
- 2004-03-16 BR BRPI0408920-0A patent/BRPI0408920A/pt not_active IP Right Cessation
- 2004-03-16 DE DE502004009059T patent/DE502004009059D1/de not_active Expired - Lifetime
- 2004-03-16 AT AT07016889T patent/ATE423766T1/de not_active IP Right Cessation
- 2004-03-16 RS YUP-2005/0719A patent/RS51146B/sr unknown
- 2004-03-16 PT PT07016889T patent/PT1862455E/pt unknown
- 2004-03-16 EP EP04720854A patent/EP1613589B1/de not_active Expired - Lifetime
- 2004-03-16 PT PT04720854T patent/PT1613589E/pt unknown
- 2004-03-16 PL PL07016889T patent/PL1862455T3/pl unknown
- 2004-03-16 ES ES07016889T patent/ES2322876T3/es not_active Expired - Lifetime
- 2004-03-16 DK DK04720854T patent/DK1613589T3/da active
- 2004-03-16 DE DE502004006195T patent/DE502004006195D1/de not_active Expired - Lifetime
- 2004-03-16 NZ NZ542751A patent/NZ542751A/en unknown
- 2004-03-16 JP JP2006504695A patent/JP2006522040A/ja active Pending
- 2004-03-16 CN CNB2004800084976A patent/CN100361970C/zh not_active Expired - Fee Related
- 2004-03-16 WO PCT/EP2004/002690 patent/WO2004087655A1/de active IP Right Grant
- 2004-03-16 AT AT04720854T patent/ATE386020T1/de not_active IP Right Cessation
- 2004-03-16 EP EP07016889A patent/EP1862455B1/de not_active Expired - Lifetime
- 2004-03-16 RU RU2005133631/04A patent/RU2334737C2/ru not_active IP Right Cessation
- 2004-03-16 SI SI200430681T patent/SI1613589T1/sl unknown
- 2004-03-16 CN CNA2007101491852A patent/CN101139306A/zh active Pending
- 2004-03-16 UA UAA200510204A patent/UA80754C2/uk unknown
- 2004-03-16 SI SI200431100T patent/SI1862455T1/sl unknown
- 2004-03-16 CA CA002520689A patent/CA2520689A1/en not_active Abandoned
- 2004-03-29 HN HN2004000109A patent/HN2004000109A/es unknown
- 2004-03-29 PE PE2004000330A patent/PE20050011A1/es not_active Application Discontinuation
- 2004-03-30 TW TW093108581A patent/TW200504009A/zh unknown
- 2004-03-30 AR ARP040101052A patent/AR043783A1/es unknown
- 2004-03-30 PA PA20048599401A patent/PA8599401A1/es unknown
- 2004-03-31 SV SV2004001756A patent/SV2004001756A/es not_active Application Discontinuation
- 2004-03-31 US US10/813,954 patent/US7205290B2/en not_active Expired - Fee Related
- 2004-03-31 GT GT200400058A patent/GT200400058A/es unknown
- 2004-03-31 MY MYPI20041165A patent/MY136269A/en unknown
- 2004-03-31 UY UY28253A patent/UY28253A1/es unknown
- 2004-04-01 CL CL200400708A patent/CL43489B/es active
- 2004-06-09 SA SA04250154A patent/SA04250154B1/ar unknown
2005
- 2005-08-22 ZA ZA200506708A patent/ZA200506708B/en unknown
- 2005-09-19 CR CR7995A patent/CR7995A/es unknown
- 2005-09-22 NI NI200500164A patent/NI200500164A/es unknown
- 2005-09-30 MA MA28529A patent/MA27753A1/fr unknown
- 2005-09-30 TN TNP2005000244A patent/TNSN05244A1/en unknown
- 2005-09-30 HR HR20050870A patent/HRP20050870A2/xx not_active Application Discontinuation
- 2005-09-30 EC EC2005006071A patent/ECSP056071A/es unknown
- 2005-10-27 NO NO20055001A patent/NO20055001L/no not_active Application Discontinuation
2006
- 2006-07-13 HK HK06107823A patent/HK1087697A1/xx not_active IP Right Cessation
2007
- 2007-03-26 US US11/690,993 patent/US7772429B2/en not_active Expired - Fee Related
2008
- 2008-04-17 CY CY20081100429T patent/CY1107398T1/el unknown
2009
- 2009-05-11 CY CY20091100503T patent/CY1109055T1/el unknown

Also Published As

Publication number	Publication date
GT200400058A (es)	2004-11-10
PT1613589E (pt)	2008-03-27
NO20055001L (no)	2005-10-27
ES2298731T3 (es)	2008-05-16
US7772429B2 (en)	2010-08-10
CL43489B (es)	2005-01-21
RU2005133631A (ru)	2006-03-10
DE502004009059D1 (de)	2009-04-09
AU2004226287B2 (en)	2010-03-18
RS20050719A (en)	2008-04-04
ATE423766T1 (de)	2009-03-15
PA8599401A1 (es)	2004-10-08
MXPA05010128A (es)	2005-11-16
HN2004000109A (es)	2008-02-21
US20050020563A1 (en)	2005-01-27
RU2334737C2 (ru)	2008-09-27
BRPI0408920A (pt)	2006-03-28
CN101139306A (zh)	2008-03-12
MY136269A (en)	2008-09-30
NZ542751A (en)	2007-05-31
HRP20050870A2 (en)	2006-10-31
RS51146B (sr)	2010-10-31
CY1107398T1 (el)	2012-12-19
JO2493B1 (en)	2009-10-05
US7205290B2 (en)	2007-04-17
UY28253A1 (es)	2004-11-08
US20070197498A1 (en)	2007-08-23
AR043783A1 (es)	2005-08-10
WO2004087655A1 (de)	2004-10-14
HK1087697A1 (en)	2006-10-20
EP1862455A2 (de)	2007-12-05
KR20050119180A (ko)	2005-12-20
DK1613589T3 (da)	2008-06-09
PT1862455E (pt)	2009-04-23
EP1862455A3 (de)	2007-12-12
EP1862455B1 (de)	2009-02-25
ATE386020T1 (de)	2008-03-15
DK1862455T3 (da)	2009-06-02
AU2004226287A1 (en)	2004-10-14
CN100361970C (zh)	2008-01-16
PE20050011A1 (es)	2005-02-28
CY1109055T1 (el)	2014-07-02
CA2520689A1 (en)	2004-10-14
DE10314610A1 (de)	2004-11-04
ECSP056071A (es)	2006-01-27
MEP41408A (en)	2011-02-10
SI1613589T1 (sl)	2008-06-30
CN1768034A (zh)	2006-05-03
TW200504009A (en)	2005-02-01
EP1613589A1 (de)	2006-01-11
TNSN05244A1 (en)	2007-06-11
SV2004001756A (es)	2004-11-18
SA04250154B1 (ar)	2007-10-29
EP1613589B1 (de)	2008-02-13
UA80754C2 (en)	2007-10-25
CR7995A (es)	2006-09-22
ZA200506708B (en)	2007-01-31
ES2322876T3 (es)	2009-06-30
NI200500164A (es)	2006-01-11
PL1862455T3 (pl)	2009-07-31
MA27753A1 (fr)	2006-02-01
DE502004006195D1 (de)	2008-03-27
SI1862455T1 (sl)	2009-06-30
JP2006522040A (ja)	2006-09-28

Publication	Publication Date	Title
HK1087697A1 (en)	2006-10-20	Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter
HK1250708A1 (zh)	2019-01-11	8-[3-氨基-呱啶-1-基]-黃嘌呤化合物，其製備方法及作為藥物製劑的用途
IL173204A0 (en)	2006-06-11	Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments
PL375344A1 (pl)	2005-11-28	Nowe związki karboksyamidowe działające antagonistycznie wobec MCH, środki medyczne zawierające te związki oraz sposoby ich wytwarzania
AU2003270262A1 (en)	2004-05-04	Novel beta mimetics with extended duration of action, method for production and use thereof as medicaments
AU2003292239A8 (en)	2004-07-14	Novel carboxamides, the production and use thereof as medicaments
PL378065A1 (pl)	2006-02-20	Podstawione związki N-aryloheterocykliczne, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych
IL175245A0 (en)	2006-09-05	Thiozolidinones, production and use thereof as medicaments
HRP20041203A2 (en)	2005-06-30	Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
IL191926A0 (en)	2008-12-29	Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
HK1081965A1 (en)	2006-05-26	Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
PL364097A1 (pl)	2004-06-28	Kompozycja polisiloksanu, sposób jej otrzymywaniai kształtowany produkt
HK1089671A1 (en)	2006-12-08	Novel imidazole derivatives, the production thereof, and the use of the same as a medicament
ZA200506422B (en)	2007-02-28	Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds
HK1076095A1 (en)	2006-01-06	Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
IL173918A0 (en)	2006-07-05	Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same
HK1076460A1 (en)	2006-01-20	Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
AU2003294952A8 (en)	2004-08-23	3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same
IL162562A0 (en)	2005-11-20	Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolid
SI1509498T1 (sl)	2007-04-30	Pentafluorosulfanil-benzoilgvanidini, postopek za njihovo pripravo, njihova uporaba kot zdravilo ali diagnosticno sredstvo in zdravilo, ki jih vsebuje
SI1513834T1 (sl)	2006-06-30	Substituirani tiofeni, postopek za njihovo pripravo, njihova uporaba kot zdravilo ali kot diagnostik kot tudi zdravilo, ki jih vsebuje
SI1560826T1 (sl)	2006-08-31	Spojine piridopirimidinona, postopek za njihovo pripravo in farmacevtski sestavki, ki te vsebujejo
AU2004242820B2 (en)	2009-02-12	Novel imidazole derivatives, the production thereof, and the use of the same as a medicament
AU2003258533A8 (en)	2004-02-23	Carboxamides, production and use thereof as medicaments____